Daxor (DXR) Announces New BVA-100 Blood Volume Analyzer Placement in New York

July 18, 2012 8:34 AM EDT Send to a Friend
Get Alerts DXR Hot Sheet
Trade DXR Now!
Daxor Corporation (AMEX: DXR), announced the placement of Daxor's BVA-100 Blood Volume Analyzer at New York Presbyterian/Weill Cornell Medical Center.

Tracing their roots back to 1771, the New York Presbyterian/Weill Cornell Medical Center is one of the most acclaimed healthcare institutions in history. New York Presbyterian is a Level I Trauma Center for pediatric and adult patients, as well as a Stroke, Hyperbaric, PCI and Burn Center. Based in New York City, they are the nation's largest not-for-profit, non-sectarian hospital, with 2,409 beds. The Hospital has nearly 2 million inpatient and outpatient visits in a year, including 12,797 deliveries and 195,294 visits to its emergency departments. NewYork-Presbyterian's 6,144 affiliated physicians and 19,376 staff provide state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine at five major centers: The Allen Hospital, Morgan Stanley Children's Hospital of New York-Presbyterian, New York-Presbyterian Hospital/Columbia University Medical Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York-Presbyterian Hospital/Westchester Division.

New York Presbyterian has just been ranked #7 in the 2012 U.S. News and World Report for Best Hospitals in the entire United States and #1 in the New York/New Jersey region.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Corporate News

Related Entities

Morgan Stanley

Add Your Comment